List of insiders holdings for INCYTE CORP:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| 1 | Baker Bros. Capital (GP) LLC BAKER JULIAN BAKER FELIX Director 10% Owner | 2017-02-22 16:47:01 | 34,389,438 0 | 34,389,438 | Form 13D |
| 2 | BAKER BIOTECH CAPITAL II GP LLC BAKER FELIX BAKER JULIAN 10% Owner | 2017-02-22 16:47:01 | 34,389,438 0 | 34,389,438 | Form 13D |
| 3 | Baker Brothers Life Sciences Capital (GP) LLC BAKER JULIAN BAKER FELIX Director 10% Owner | 2017-02-22 16:47:01 | 34,389,438 0 | 34,389,438 | Form 13D |
| 4 | 14159 capital (GP) LLC BAKER JULIAN BAKER FELIX Director 10% Owner | 2017-02-22 16:47:01 | 34,389,438 0 | 34,389,438 | Form 13D |
| 5 | Baker / Tisch Capital (GP) LLC BAKER JULIAN BAKER FELIX Director 10% Owner | 2017-02-22 16:47:01 | 34,389,438 0 | 34,389,438 | Form 13D |
| 6 | Baker Biotech Capital (GP) LLC BAKER JULIAN BAKER FELIX Director 10% Owner | 2017-02-22 16:47:01 | 34,389,438 0 | 34,389,438 | Form 13D |
| 7 | BAKER BROS. ADVISORS LP 14159 L.P. 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director 10% Owner | 2026-05-11 16:59:57 | 31,225,572 0 | 31,225,572 | Form 13D |
| 8 | BAKER BROS. ADVISORS LP 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director 10% Owner | 2026-07-02 16:31:15 | 559,963 28,239,170 | 28,799,133 | Form 4 |
| 9 | TISCH ANDREW H No longer 10% owner. | 2005-02-10 11:31:03 | 1,541,669 0 | 1,541,669 | Form 13G |
| 10 | TISCH THOMAS J No longer 10% owner. | 2004-08-13 15:58:35 | 117,592 1,416,661 | 1,534,253 | Form 4/A |
| 11 | TISCH JAMES S No longer 10% owner. | 2004-08-13 15:58:06 | 117,592 1,216,661 | 1,334,253 | Form 4/A |
| 12 | TISCH DANIEL R No longer 10% owner. | 2006-04-21 12:04:18 | 1,126,669 0 | 1,126,669 | Form 13G |
| 13 | WHITFIELD ROY A Director | 2014-01-17 16:19:51 | 662,832 0 | 662,832 | Form 5 |
| 14 | Hoppenot Herve Director | 2025-12-10 16:06:42 | 326,803 0 | 326,803 | Form 4 |
| 15 | FRIEDMAN PAUL A Director | 2020-05-28 16:27:11 | 267,327 15,000 | 282,327 | Form 4 |
| 16 | BROOKE PAUL A Director | 2020-04-02 17:01:14 | 221,911 40,000 | 261,911 | Form 4 |
| 17 | CAGNONI PABLO J President, Global Head of R&D | 2026-06-03 16:58:30 | 240,848 0 | 240,848 | Form 4 |
| 18 | HASTINGS DAVID C Chief Financial Officer | 2014-06-06 18:47:53 | 227,470 0 | 227,470 | Form 4 |
| 19 | Stamoulis Christiana EVP & Chief Financial Officer | 2025-07-16 16:03:58 | 178,526 0 | 178,526 | Form 4 |
| 20 | Meury William Chief Executive Officer | 2026-07-07 16:09:36 | 156,322 0 | 156,322 | Form 4 |
| 21 | SWAIN PAULA J EVP, Human Resources | 2025-07-16 16:04:38 | 137,031 0 | 137,031 | Form 4 |
| 22 | Wenqing Yao EVP, Head of Discovery Chem | 2021-07-07 17:54:42 | 113,629 0 | 113,629 | Form 4 |
| 23 | Andrews Patricia S Chief Commercial Officer | 2012-01-23 16:43:17 | 100,000 0 | 100,000 | Form 4 |
| 24 | KELLER JOHN A Chief Business Officer | 2008-02-11 17:28:56 | 100,000 0 | 100,000 | Form 4 |
| 25 | DE SCHUTTER RICHARD U Chairman | 2015-03-09 16:35:21 | 99,821 0 | 99,821 | Form 4 |
| 26 | Upadhyay Suketu EVP & Chief Financial Officer | 2026-05-06 16:34:55 | 91,114 0 | 91,114 | Form 4 |
| 27 | Pasquale Maria E EVP & General Counsel | 2023-07-18 16:00:15 | 89,999 0 | 89,999 | Form 4 |
| 28 | SAXE JON S Director | 2004-04-01 14:08:05 | 80,000 0 | 80,000 | Form 4 |
| 29 | Hoffman Richard A. EVP & General Counsel | 2025-12-03 16:35:43 | 76,432 0 | 76,432 | Form 4 |
| 30 | Stein Steven H CMO & Head of Late-Stage Dev. | 2026-07-07 16:09:07 | 76,150 0 | 76,150 | Form 4 |
| 31 | Gardner David H EVP, Chief Strategy Officer | 2025-09-24 16:35:50 | 75,901 0 | 75,901 | Form 4 |
| 32 | Dhanak Dashyant EVP & Chief Scientific Officer | 2023-07-18 16:00:18 | 75,864 0 | 75,864 | Form 4 |
| 33 | Daly James M EVP, Chief Commercial Officer | 2015-06-25 16:28:05 | 71,283 0 | 71,283 | Form 4 |
| 34 | METCALF BRIAN W Chief Drug Discovery Scientist | 2011-04-13 16:09:01 | 66,504 0 | 66,504 | Form 4 |
| 35 | Mayes Patrick A EVP & Chief Scientific Officer | 2026-07-07 16:10:19 | 59,661 0 | 59,661 | Form 4 |
| 36 | Basi Ramitpal K EVP, Human Resources | 2025-08-27 16:43:20 | 52,001 0 | 52,001 | Form 4 |
| 37 | ARIKO BARRY A Director | 2015-03-13 16:28:02 | 45,834 0 | 45,834 | Form 4 |
| 38 | Iyengar Vijay K EVP, GMAPPS | 2025-07-17 16:05:27 | 40,540 0 | 40,540 | Form 4 |
| 39 | HURLEY SCOTT W VP/Corp Controller & Treasurer | 2005-01-27 12:58:59 | 40,000 0 | 40,000 | Form 4 |
| 40 | Heeson Lee EVP, Head of Incyte Intl | 2026-02-04 16:07:01 | 38,041 0 | 38,041 | Form 4 |
| 41 | Dickinson Jonathan Elliott EVP, General Manager, Europe | 2024-09-16 13:24:17 | 36,390 0 | 36,390 | Form 4 |
| 42 | Denton Sheila A. EVP & General Counsel | 2025-11-19 16:08:38 | 35,452 0 | 35,452 | Form 4 |
| 43 | Flannelly Barry P EVP & General Manager US | 2025-07-17 16:06:01 | 35,149 0 | 35,149 | Form 4 |
| 44 | Huber Reid M EVP, Chief Scientific Officer | 2018-07-18 16:28:26 | 34,571 0 | 34,571 | Form 4 |
| 45 | Morrissey Michael James EVP, Head of Tech. Operations | 2026-02-04 16:07:23 | 34,065 0 | 34,065 | Form 4 |
| 46 | FBB Associates Director 10% Owner | 2012-06-18 17:33:56 | 33,410 0 | 33,410 | Form 3 |
| 47 | BIENAIME JEAN JACQUES Director | 2026-06-10 16:06:09 | 30,535 0 | 30,535 | Form 4 |
| 48 | FOUSE JACQUALYN A Director | 2026-06-10 16:07:26 | 27,079 0 | 27,079 | Form 4 |
| 49 | Clancy Paul J Director | 2026-07-02 16:08:07 | 25,635 0 | 25,635 | Form 4 |
| 50 | HARRIGAN EDMUND Director | 2026-07-02 16:07:20 | 23,019 0 | 23,019 | Form 4 |
| 51 | SCHRECK PATRICIA A EVP, General Counsel | 2011-05-11 16:17:53 | 22,276 0 | 22,276 | Form 4 |
| 52 | High Katherine A Director | 2026-06-10 16:05:47 | 21,094 0 | 21,094 | Form 4 |
| 53 | Siegel Eric H. EVP, General Counsel | 2017-09-15 16:28:33 | 21,053 0 | 21,053 | Form 4 |
| 54 | Tray Thomas Principal Accounting Officer | 2026-07-07 16:09:59 | 20,655 0 | 20,655 | Form 4 |
| 55 | CRAVES FRED B Director | 2005-06-03 09:43:51 | 20,000 0 | 20,000 | Form 4 |
| 56 | Emmens Matthew Director | 2008-05-22 16:32:43 | 20,000 0 | 20,000 | Form 4 |
| 57 | NIBLACK JOHN F Director | 2011-05-23 16:38:41 | 20,000 0 | 20,000 | Form 4 |
| 58 | Levy Richard S EVP, Chief Drug Dev Officer | 2016-01-08 16:37:56 | 19,802 0 | 19,802 | Form 4 |
| 59 | BRAWLEY OTIS W Director | 2026-06-10 16:05:26 | 19,005 0 | 19,005 | Form 4 |
| 60 | DIXON WENDY L Director | 2022-04-04 16:00:32 | 17,768 0 | 17,768 | Form 4 |
| 61 | Schaffert Susanne Director | 2025-06-12 16:28:33 | 16,605 0 | 16,605 | Form 4 |
| 62 | Chardonnet Laurent Vice President and Treasurer | 2015-04-01 16:27:38 | 15,129 0 | 15,129 | Form 4 |
| 63 | FBB2 LLC Director 10% Owner | 2012-06-18 17:35:48 | 15,110 0 | 15,110 | Form 3 |
| 64 | Friedman Steven M. EVP, Biology & Preclinical Dev | 2010-05-20 16:11:55 | 15,000 0 | 15,000 | Form 4 |
| 65 | Trotta Matteo EVP, GM, Dermatology US | 2026-03-26 16:13:52 | 14,882 0 | 14,882 | Form 4 |
| 66 | Issa Mohamed Khairie EVP, Head of US Oncology | 2026-01-21 16:06:10 | 14,237 0 | 14,237 | Form 4 |
| 67 | GRYSKA DAVID W Executive Vice President, CFO | 2018-07-18 16:12:41 | 10,235 0 | 10,235 | Form 4 |
| 68 | Trower Paul Principal Accounting Officer | 2022-01-21 16:37:50 | 3,250 0 | 3,250 | Form 4 |
| 69 | PLATINUM ASSET MANAGEMENT LTD 10% Owner | 2009-02-10 18:56:09 | 0 0 | 0 | Form 13G |
| 70 | DAMIAL FOUNDATION INC 10% Owner | 2004-02-13 19:51:28 | 0 0 | 0 | Form 4 |
| 71 | TISCH BONNIE J 10% Owner | 2004-01-16 16:57:59 | 0 0 | 0 | Form 4 |